ID

34303

Descrizione

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD); ODM derived from: https://clinicaltrials.gov/show/NCT01295710

collegamento

https://clinicaltrials.gov/show/NCT01295710

Keywords

  1. 16/01/19 16/01/19 -
Titolare del copyright

see on clinicaltrials.gov

Caricato su

16 gennaio 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility GVHD NCT01295710

Eligibility GVHD NCT01295710

  1. StudyEvent: Eligibility
    1. Eligibility GVHD NCT01295710
Criteria
Descrizione

Criteria

patients designated to undergo allogeneic peripheral blood or bone marrow stem cell transplantation following the diagnosis of one of the primary diseases in early or intermediate disease status (i.e., acute myeloid leukemia, acute lymphoid leukemia, and myelodysplastic syndrome)
Descrizione

ID.1

Tipo di dati

boolean

patients with an unrelated hla-a,-b, -c and -drbi matched donor
Descrizione

ID.2

Tipo di dati

boolean

patients with a karnofsky performance score ≥ 70%
Descrizione

ID.3

Tipo di dati

boolean

key exclusion criteria:
Descrizione

ID.4

Tipo di dati

boolean

clinically significant concomitant diseases (i.e., cardiac, pulmonary, renal and cns)
Descrizione

ID.5

Tipo di dati

boolean

bacterial, viral, or fungal infections
Descrizione

ID.6

Tipo di dati

boolean

known positive for hepatitis b surfaces antigen, or hepatitis c antibody, or who have been tested positive for hiv
Descrizione

ID.7

Tipo di dati

boolean

patients with any concurrent malignancy. cancer treated with curative intent < 5 years previously will not be allowed except for patients with resected basal cell carcinoma or treated cervical carcinoma in situ
Descrizione

ID.8

Tipo di dati

boolean

known contraindications to the administration of rabbit immunoglobulin antibodies
Descrizione

ID.9

Tipo di dati

boolean

hypersensitivity to methylprednisolone, tacrolimus, methotrexate or any excipients contains in these products
Descrizione

ID.10

Tipo di dati

boolean

Similar models

Eligibility GVHD NCT01295710

  1. StudyEvent: Eligibility
    1. Eligibility GVHD NCT01295710
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
ID.1
Item
patients designated to undergo allogeneic peripheral blood or bone marrow stem cell transplantation following the diagnosis of one of the primary diseases in early or intermediate disease status (i.e., acute myeloid leukemia, acute lymphoid leukemia, and myelodysplastic syndrome)
boolean
ID.2
Item
patients with an unrelated hla-a,-b, -c and -drbi matched donor
boolean
ID.3
Item
patients with a karnofsky performance score ≥ 70%
boolean
ID.4
Item
key exclusion criteria:
boolean
ID.5
Item
clinically significant concomitant diseases (i.e., cardiac, pulmonary, renal and cns)
boolean
ID.6
Item
bacterial, viral, or fungal infections
boolean
ID.7
Item
known positive for hepatitis b surfaces antigen, or hepatitis c antibody, or who have been tested positive for hiv
boolean
ID.8
Item
patients with any concurrent malignancy. cancer treated with curative intent < 5 years previously will not be allowed except for patients with resected basal cell carcinoma or treated cervical carcinoma in situ
boolean
ID.9
Item
known contraindications to the administration of rabbit immunoglobulin antibodies
boolean
ID.10
Item
hypersensitivity to methylprednisolone, tacrolimus, methotrexate or any excipients contains in these products
boolean

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial